Publications:
Results of a quality improvement program to increase complete lung cancer biomarker testing rates by focusing on system, physician, and other factors associated with adverse health outcomes
Journal of Clinical Oncology 42, 2024 (suppl 16; abstr e23249)
doi.org/10.1200/JCO.2024.42.16_suppl.e23249
Evaluating perceived barriers to optimal care in head and neck cancer: A mixed-methods study
Journal of Clinical Oncology 42, 2024 (suppl 16; abstr 6079)
doi.org/10.1200/JCO.2024.42.16_suppl.6079
Integrating electronic health records (EHRs) to facilitate cancer biomarker testing: Real-world implementation barriers and solutions
Journal of Clinical Oncology 42, 2024 (suppl 16; abstr e13649)
doi.org/10.1200/JCO.2024.42.16_suppl.e13649
Results of a quality improvement program to increase complete lung cancer biomarker testing rates
JCO Oncology Practice 2023 19:11_suppl, 57-57.
doi.org/10.1200/OP.2023.19.11_suppl.57
Key Considerations when Evaluating Whether to Establish a PD-L1 Laboratory Developed Test (LDT)
American Journal of Clinical Pathology, Volume 160, Issue Supplement_1, November 2023, Page S90
doi.org/10.1093/ajcp/aqad150.199
Disseminating Education about HER2-Low Breast Cancer through Twitter Chats and Tweetorials
American Journal of Clinical Pathology, Volume 160, Issue Supplement_1, November 2023, Pages S97–S98
doi.org/10.1093/ajcp/aqad150.215
EP12.02-10 Personalizing Care for Patients with Advanced ALK+ NSCLC through a Blended Continuing Education and Quality Improvement Initiative
Journal of Thoracic Oncology, Volume 18, Issue 11, S678
doi.org/10.1016/j.jtho.2023.09.1303
EP07.04-22 Current Biomarker Testing Practices for Early Stage Non-small Cell Lung Cancer (NSCLC) In Community and Academic Centers in the US
Journal of Thoracic Oncology, Volume 18, Issue 11, S554
doi.org/10.1016/j.jtho.2023.09.1035
The Emerging Role of Precision Medicine Stewards for Cancer Biomarker Navigation
Journal of Oncology Navigation & Survivorship October 2023 Vol 14, No 10 —October 26, 2023
www.jons-online.com/issues/2023/october-2023-vol-14-no-10/4973-category-ii-care-coordination-care-transitions#B12
Care Coordination Strategies for Patients Receiving Combination IV and Oral Anticancer Therapy: Findings for Advanced Practitioners From a National Mixed-Methods Study
Journal of the Advanced Practitioner in Oncology 2023 Jan; 14(1): 1–28.
www.ncbi.nlm.nih.gov/pmc/articles/PMC9894201/#sec7title
Emerging Biomarkers: Innovative Therapies for Rare Disease
Oncology Issues 2023;38(4):76–80
doi.org/10.3928/25731777-20230710-11
Improving guideline-concordant biomarker testing through implementation of a precision cancer medicine steward
Journal of Clinical Oncology 2023 41:16_suppl, e18706-e18706
doi.org/10.1200/JCO.2023.41.16_suppl.e18706
Assessing current diagnostic, staging, and treatment practices in community and academic centers for individuals with stage IB-IIIA non–small-cell lung cancer (NSCLC)
Journal of Clinical Oncology 2023 41:16_suppl, e20608-e20608
doi.org/10.1200/JCO.2023.41.16_suppl.e20608
Abstract P6-04-19: Engaging pathologists in a social peer-to-peer learning collaborative to discuss the emergence of HER2-low breast cancer
Cancer Research (2023) 83 (5_Supplement): P6-04-19
doi.org/10.1158/1538-7445.SABCS22-P6-04-19
Reducing preventable ED visits in patients with advanced NSCLC: Collective insights from three cancer centers
Journal of Clinical Oncology
doi.org/10.1200/JCO.2022.40.28_suppl.337
Leveraging continuing education and implementation science approaches to improve the care of patients with myeloproliferative neoplasms
Journal of Clinical Oncology
doi.org/10.1200/JCO.2022.40.28_suppl.334
Empowering pathologists to lead immuno-oncology (IO) biomarker testing in the community
Journal of Clinical Oncology
doi.org/10.1200/JCO.2022.40.28_suppl.348
A mixed-methods study to identify key priorities around improving team-based care coordination for patients receiving combination IV and oral systemic anti-cancer therapy
Journal of Clinical Oncology
doi.org/10.1200/JCO.2022.40.28_suppl.052
Care Coordination Strategies for Patients Receiving Combination IV and Oral Anticancer Therapy: Findings for Advanced Practitioners From a National Mixed-Methods Study
Journal of the Advanced Practitioner in Oncology
doi.org/10.6004/jadpro.2023.14.1.10
Association of Community Cancer Centers key quality care recommendations for stage IB to IIIA non–small cell lung cancer
Journal of Clinical Oncology
doi.org/10.1200/JCO.2022.40.28_suppl.030
Building a multidisciplinary consortium in Iowa to advance genetic counseling and testing in patients with cancer
Journal of Clinical Oncology
doi.org/10.1200/JCO.2022.40.16_suppl.10609
A multiphase continuing education and quality improvement initiative to tailor treatment plans for patients with follicular lymphoma
Journal of Clinical Oncology
doi.org/10.1200/JCO.2022.40.16_suppl.e18651
Enhancing Coordination Around Cancer Biomarker and Hereditary Genetic Testing Among Members of the Multidisciplinary Care Team
American Journal of Clinical Pathology
doi.org/10.1093/ajcp/aqac126.310
Leadership Insights From a Pathology Peer-to-Peer Learning Collaborative in Immuno-oncology
American Journal of Clinical Pathology
doi.org/10.1093/ajcp/aqac126.309
Engaging Pathologists in a Peer-to-Peer Learning Collaborative on HER2-Low Breast Cancer
American Journal of Clinical Pathology
doi.org/10.1093/ajcp/aqac126.082
Learnings from a multiphase, mixed-methods lung cancer quality initiative in U.S. community cancer centers
Journal of Clinical Oncology
doi.org/10.1200/JCO.2020.39.28_suppl.254
P53.06 A Multi-Phase Quality Initiative to Improve Processes of Care for Non-small Cell Lung Cancer (NSCLC) in US Community Cancer Centers
Journal of Thoracic Oncology
doi.org/10.1016/j.jtho.2021.08.555
EP1.16-02 Proactively Improving the Management of Immune-Related Adverse Events (irAEs) in a Community Cancer Program
Journal of Thoracic Oncology
doi.org/10.1016/j.jtho.2019.08.2367
Improving Process of Care Measures For Patients With IBD: Key Findings From A QI Pilot
Inflammatory Bowel Diseases
doi.org/10.1093/ibd/izy038.022
Journal of Clinical Oncology 42, 2024 (suppl 16; abstr e23249)
doi.org/10.1200/JCO.2024.42.16_suppl.e23249
Evaluating perceived barriers to optimal care in head and neck cancer: A mixed-methods study
Journal of Clinical Oncology 42, 2024 (suppl 16; abstr 6079)
doi.org/10.1200/JCO.2024.42.16_suppl.6079
Integrating electronic health records (EHRs) to facilitate cancer biomarker testing: Real-world implementation barriers and solutions
Journal of Clinical Oncology 42, 2024 (suppl 16; abstr e13649)
doi.org/10.1200/JCO.2024.42.16_suppl.e13649
Results of a quality improvement program to increase complete lung cancer biomarker testing rates
JCO Oncology Practice 2023 19:11_suppl, 57-57.
doi.org/10.1200/OP.2023.19.11_suppl.57
Key Considerations when Evaluating Whether to Establish a PD-L1 Laboratory Developed Test (LDT)
American Journal of Clinical Pathology, Volume 160, Issue Supplement_1, November 2023, Page S90
doi.org/10.1093/ajcp/aqad150.199
Disseminating Education about HER2-Low Breast Cancer through Twitter Chats and Tweetorials
American Journal of Clinical Pathology, Volume 160, Issue Supplement_1, November 2023, Pages S97–S98
doi.org/10.1093/ajcp/aqad150.215
EP12.02-10 Personalizing Care for Patients with Advanced ALK+ NSCLC through a Blended Continuing Education and Quality Improvement Initiative
Journal of Thoracic Oncology, Volume 18, Issue 11, S678
doi.org/10.1016/j.jtho.2023.09.1303
EP07.04-22 Current Biomarker Testing Practices for Early Stage Non-small Cell Lung Cancer (NSCLC) In Community and Academic Centers in the US
Journal of Thoracic Oncology, Volume 18, Issue 11, S554
doi.org/10.1016/j.jtho.2023.09.1035
The Emerging Role of Precision Medicine Stewards for Cancer Biomarker Navigation
Journal of Oncology Navigation & Survivorship October 2023 Vol 14, No 10 —October 26, 2023
www.jons-online.com/issues/2023/october-2023-vol-14-no-10/4973-category-ii-care-coordination-care-transitions#B12
Care Coordination Strategies for Patients Receiving Combination IV and Oral Anticancer Therapy: Findings for Advanced Practitioners From a National Mixed-Methods Study
Journal of the Advanced Practitioner in Oncology 2023 Jan; 14(1): 1–28.
www.ncbi.nlm.nih.gov/pmc/articles/PMC9894201/#sec7title
Emerging Biomarkers: Innovative Therapies for Rare Disease
Oncology Issues 2023;38(4):76–80
doi.org/10.3928/25731777-20230710-11
Improving guideline-concordant biomarker testing through implementation of a precision cancer medicine steward
Journal of Clinical Oncology 2023 41:16_suppl, e18706-e18706
doi.org/10.1200/JCO.2023.41.16_suppl.e18706
Assessing current diagnostic, staging, and treatment practices in community and academic centers for individuals with stage IB-IIIA non–small-cell lung cancer (NSCLC)
Journal of Clinical Oncology 2023 41:16_suppl, e20608-e20608
doi.org/10.1200/JCO.2023.41.16_suppl.e20608
Abstract P6-04-19: Engaging pathologists in a social peer-to-peer learning collaborative to discuss the emergence of HER2-low breast cancer
Cancer Research (2023) 83 (5_Supplement): P6-04-19
doi.org/10.1158/1538-7445.SABCS22-P6-04-19
Reducing preventable ED visits in patients with advanced NSCLC: Collective insights from three cancer centers
Journal of Clinical Oncology
doi.org/10.1200/JCO.2022.40.28_suppl.337
Leveraging continuing education and implementation science approaches to improve the care of patients with myeloproliferative neoplasms
Journal of Clinical Oncology
doi.org/10.1200/JCO.2022.40.28_suppl.334
Empowering pathologists to lead immuno-oncology (IO) biomarker testing in the community
Journal of Clinical Oncology
doi.org/10.1200/JCO.2022.40.28_suppl.348
A mixed-methods study to identify key priorities around improving team-based care coordination for patients receiving combination IV and oral systemic anti-cancer therapy
Journal of Clinical Oncology
doi.org/10.1200/JCO.2022.40.28_suppl.052
Care Coordination Strategies for Patients Receiving Combination IV and Oral Anticancer Therapy: Findings for Advanced Practitioners From a National Mixed-Methods Study
Journal of the Advanced Practitioner in Oncology
doi.org/10.6004/jadpro.2023.14.1.10
Association of Community Cancer Centers key quality care recommendations for stage IB to IIIA non–small cell lung cancer
Journal of Clinical Oncology
doi.org/10.1200/JCO.2022.40.28_suppl.030
Building a multidisciplinary consortium in Iowa to advance genetic counseling and testing in patients with cancer
Journal of Clinical Oncology
doi.org/10.1200/JCO.2022.40.16_suppl.10609
A multiphase continuing education and quality improvement initiative to tailor treatment plans for patients with follicular lymphoma
Journal of Clinical Oncology
doi.org/10.1200/JCO.2022.40.16_suppl.e18651
Enhancing Coordination Around Cancer Biomarker and Hereditary Genetic Testing Among Members of the Multidisciplinary Care Team
American Journal of Clinical Pathology
doi.org/10.1093/ajcp/aqac126.310
Leadership Insights From a Pathology Peer-to-Peer Learning Collaborative in Immuno-oncology
American Journal of Clinical Pathology
doi.org/10.1093/ajcp/aqac126.309
Engaging Pathologists in a Peer-to-Peer Learning Collaborative on HER2-Low Breast Cancer
American Journal of Clinical Pathology
doi.org/10.1093/ajcp/aqac126.082
Learnings from a multiphase, mixed-methods lung cancer quality initiative in U.S. community cancer centers
Journal of Clinical Oncology
doi.org/10.1200/JCO.2020.39.28_suppl.254
P53.06 A Multi-Phase Quality Initiative to Improve Processes of Care for Non-small Cell Lung Cancer (NSCLC) in US Community Cancer Centers
Journal of Thoracic Oncology
doi.org/10.1016/j.jtho.2021.08.555
EP1.16-02 Proactively Improving the Management of Immune-Related Adverse Events (irAEs) in a Community Cancer Program
Journal of Thoracic Oncology
doi.org/10.1016/j.jtho.2019.08.2367
Improving Process of Care Measures For Patients With IBD: Key Findings From A QI Pilot
Inflammatory Bowel Diseases
doi.org/10.1093/ibd/izy038.022
Bottles K, Kim J. How physician leaders can use social media to crowdsource. Physician Exec. 2014 Jan-Feb;40(1):82-4.
Bottles K, Kim J. Evolving trends in social media compliance in medicine. Physician Exec. 2013 Sep-Oct;39(5):96-8.
Bottles K, Kim J. Generational attitudes affect adoption of social media by physician leaders.
Physician Exec. 2013 Jul-Aug;39(4):94-6.
Bottles K, Kim J. Presentations offer insight on social media for physicians. Physician Exec. 2013 May-Jun;39(3):92-3.
Bottles K, Kim J. The evolving involvement of physicians using social media. Physician Exec. 2013 Mar-Apr;39(2):86-8.
Kim J. Teaching medical students about management, business, and leadership. Physician Exec. 2012 May-Jun;38(3):80-2.
Kim J. Exploring alternative careers through informational interviews. Physician Exec. 2011 Nov-Dec;37(6):90-2.
Kim J. Understanding the CME enterprise. Physician Exec. 2011 Sep-Oct;37(5):62-4.
Kim J. Technology Jobs for Physician Leaders. Physician Exec. 2011 Jul-Aug;39(4):88-91.
Kim J. Pursuing an MBA: my personal journey as a physician executive. Physician Exec. 2011 Mar-Apr;37(2):74-6.
Kim J. Retirees may consider non-clinical "encore" career. Physician Exec. 2011 Jan-Feb;37(1):78-81.
Kim J. Non-clinical career opportunities for physician executives. Physician Exec. 2010 Nov-Dec;36(6):82-5.
Bottles K, Kim J. Evolving trends in social media compliance in medicine. Physician Exec. 2013 Sep-Oct;39(5):96-8.
Bottles K, Kim J. Generational attitudes affect adoption of social media by physician leaders.
Physician Exec. 2013 Jul-Aug;39(4):94-6.
Bottles K, Kim J. Presentations offer insight on social media for physicians. Physician Exec. 2013 May-Jun;39(3):92-3.
Bottles K, Kim J. The evolving involvement of physicians using social media. Physician Exec. 2013 Mar-Apr;39(2):86-8.
Kim J. Teaching medical students about management, business, and leadership. Physician Exec. 2012 May-Jun;38(3):80-2.
Kim J. Exploring alternative careers through informational interviews. Physician Exec. 2011 Nov-Dec;37(6):90-2.
Kim J. Understanding the CME enterprise. Physician Exec. 2011 Sep-Oct;37(5):62-4.
Kim J. Technology Jobs for Physician Leaders. Physician Exec. 2011 Jul-Aug;39(4):88-91.
Kim J. Pursuing an MBA: my personal journey as a physician executive. Physician Exec. 2011 Mar-Apr;37(2):74-6.
Kim J. Retirees may consider non-clinical "encore" career. Physician Exec. 2011 Jan-Feb;37(1):78-81.
Kim J. Non-clinical career opportunities for physician executives. Physician Exec. 2010 Nov-Dec;36(6):82-5.